[Utility of infliximab in gangrenous pyoderma not associated with inflammatory bowel disease]

Rev Clin Esp. 2010 Jul-Aug;210(7):367-9. doi: 10.1016/j.rce.2009.11.021. Epub 2010 May 12.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Inflammatory Bowel Diseases
  • Infliximab
  • Male
  • Middle Aged
  • Pyoderma Gangrenosum / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab